CY1847A - Anti-HIV activity of BV-3608 - Google Patents

Anti-HIV activity of BV-3608

Info

Publication number
CY1847A
CY1847A CY184796A CY184796A CY1847A CY 1847 A CY1847 A CY 1847A CY 184796 A CY184796 A CY 184796A CY 184796 A CY184796 A CY 184796A CY 1847 A CY1847 A CY 1847A
Authority
CY
Cyprus
Prior art keywords
susceptible
hiv
aids
infection
preventing
Prior art date
Application number
CY184796A
Other languages
English (en)
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of CY1847A publication Critical patent/CY1847A/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H15/00Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
    • C07H15/20Carbocyclic rings
    • C07H15/24Condensed ring systems having three or more rings
    • C07H15/244Anthraquinone radicals, e.g. sennosides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
CY184796A 1988-07-01 1996-03-08 Anti-HIV activity of BV-3608 CY1847A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US21422688A 1988-07-01 1988-07-01

Publications (1)

Publication Number Publication Date
CY1847A true CY1847A (en) 1996-03-08

Family

ID=22798273

Family Applications (1)

Application Number Title Priority Date Filing Date
CY184796A CY1847A (en) 1988-07-01 1996-03-08 Anti-HIV activity of BV-3608

Country Status (12)

Country Link
EP (1) EP0351625B1 (xx)
JP (1) JP2802336B2 (xx)
KR (1) KR0131323B1 (xx)
AT (1) ATE87827T1 (xx)
CA (1) CA1335078C (xx)
CY (1) CY1847A (xx)
DE (1) DE68905875T2 (xx)
ES (1) ES2054935T3 (xx)
GR (1) GR3007580T3 (xx)
HK (1) HK110095A (xx)
IL (1) IL90783A (xx)
ZA (1) ZA894984B (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5338728A (en) * 1992-08-14 1994-08-16 Bristol-Myers Squibb Pradimicin compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870165A (en) * 1987-02-02 1989-09-26 Bristol-Myers Company Antifungal antibiotics

Also Published As

Publication number Publication date
IL90783A0 (en) 1990-01-18
ES2054935T3 (es) 1994-08-16
IL90783A (en) 1994-01-25
EP0351625B1 (en) 1993-04-07
JP2802336B2 (ja) 1998-09-24
CA1335078C (en) 1995-04-04
HK110095A (en) 1995-07-14
ATE87827T1 (de) 1993-04-15
GR3007580T3 (xx) 1993-08-31
DE68905875T2 (de) 1993-07-15
EP0351625A1 (en) 1990-01-24
ZA894984B (en) 1990-03-28
KR0131323B1 (ko) 1998-04-17
DE68905875D1 (de) 1993-05-13
JPH0248530A (ja) 1990-02-19
KR900001374A (ko) 1990-02-27

Similar Documents

Publication Publication Date Title
DK92788A (da) Anvendelse af 3'-deoxy-3'-flourguanosider til fremstilling af laegemidler mod retrovira
EP0403251A3 (en) Monokine activity interference
DE3780016D1 (de) Pharmazeutisches praeparat mit 3'-desoxythymidin-2'-en(3'-desoxy-2',3'-didehydrothymidin) zur behandlung von patienten mit retroviralen infektionen.
AU2930889A (en) Pharmaceutical preparation for treating immunodeficiency conditions
AU8448091A (en) Novel polypeptide and anti-hiv drug prepared therefrom
ES468363A1 (es) Proceso para la fabricacion de un preparado destinado al tra-tamiento de herpes-zoster.
EP0323157A3 (en) Antiviral compounds and methods
WO1990013281A3 (en) Method of suppressing hiv infection
CY1847A (en) Anti-HIV activity of BV-3608
AU1308188A (en) Methods of treating acquired immune deficiency syndrome (AIDS) caused by human immunodeficiency virus (HIV)
EP0311108A3 (en) Anti-hiv active 3'-azido-2,6-diaminopurine-2',3'-dideoxyriboside
EP0255242A3 (en) Oncornavirus vaccines
EP0316592A3 (en) 3'-fluoro-2',3'-dideoxyuridine, and its therapeutic application
FI881123A (fi) Inaktivering av human immunodeficiency virus (hiv) medelst fenol i proteinhaltiga loesningar.
AU3335689A (en) Recombinant gag precursor of hiv, product, process, and use as aids vaccine
JPS6419023A (en) Heat treatment of fibrinogen and fibrinogen preparation
UA6149A1 (uk) 2-(2'7'-діацетоксіфлуореніліден-9'-гідразоно)-5-(п-нітробензіліден)-тіазолідон-4,що виявляє противірусну дію щодо віруса грипу а та а-2, а також віруса осповакцини
DE68929084D1 (de) Arzneimittel zur Verhinderung einer Infektion mit dem für AIDS verantwortlichen Virus
ES468457A1 (es) Un procedimiento para la produccion de un tetrapeptido
JPS6471815A (en) Antiviral composition containing 5-amino-2- (4-methylpiperidine-1-yl)phenyl-4- chlorophenylmethanone
ATE67674T1 (de) Pharmazeutische zubereitungen mit heilender aktivitaet.
ZA892996B (en) Recombinant gag precursor of hiv,product,process,and use as aids vaccine